LABD : Direxion Daily S&P Biotech Bear 3X Shares

LABD is a Alternative Market Inverse with HIGH fees.

LABD

Direxion Daily S&P Biotech Bear 3X Shares

FI Score

39 /100

Expense Ratio Rating

4 /10

Expense Rating

0 /10

Market Score

8 /10

Category Score

0 /10

Market Size

8 /10

39% FI Score
  • labd
  • ETF
  • Alternative
  • Inverse

Direxion Daily S&P Biotech Bear 3X Shares

Expenses: 1.06% (Better than 0% of similar funds)

This is a bad choice for a Inverse Alternative fund. See why ยป

Fund Summary

The investment seeks daily investment results, before fees and expenses, of 300% of the inverse of the daily performance of the S&P Biotechnology Select Industry Index. The fund, under normal circumstances, invests in swap agreements, futures contracts, short positions or other financial instruments that, in combination, provide inverse (opposite) or short leveraged exposure to the index equal to at least 80% of the fund's net assets (plus borrowing for investment purposes). The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards (GICS). The fund is non-diversified.

Largest Holdings

Amount Holding
1.95% Invitae Corporation
1.91% Exelixis, Inc
1.89% BioMarin Pharmaceutical Inc
1.87% bluebird bio, Inc
1.87% Global Blood Therapeutics, Inc
1.84% Vertex Pharmaceuticals Incorporated
1.80% Sage Therapeutics, Inc
1.78% United Therapeutics Corporation
1.77% Regeneron Pharmaceuticals, Inc
1.76% Alexion Pharmaceuticals, Inc

Minafi - The intersection of FI, minimalism & mindfulness.

Don't miss out on new posts, courses, interactive articles and more!

Join & Get Your First Course Free

© 2024   Adam Fortuna

Site Map
Triangle Graduation Cap Angle Down Book regular Phone laptop regular fire regular fire regular search regular Acorn duotone Seedling duotone thumbs down duo